| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/12/2012 | CN102813929A Low-concentration polyethylene glycol-lipid (PEG-lipid) derivative and application thereof |
| 12/12/2012 | CN102813928A Method for modifying bitter taste of berberine, berberine hydrochloride and related compound preparations |
| 12/12/2012 | CN102813699A Pharmaceutical composition having effects of heat clearing, detoxifying and anti-inflammation and preparation method thereof |
| 12/12/2012 | CN102813697A Method for improving bitter taste of motherwort total alkaloids and related preparations thereof |
| 12/12/2012 | CN102813695A Method for improving bitter taste of sophora flavescens alkaloids and related preparations thereof |
| 12/12/2012 | CN102813678A Biological Chinese patent medicine |
| 12/12/2012 | CN102813675A Compound potassium hydrogen phosphate medicine combination for injection |
| 12/12/2012 | CN102813673A Use of gold nanorod in male contraception |
| 12/12/2012 | CN102813665A Composition for synergy of doxycycline antibacterial activity and application thereof |
| 12/12/2012 | CN102813655A Formulations of a SRC/ABL inhibitor |
| 12/12/2012 | CN102813654A Matrix for sustained, invariant and independent release of active compounds |
| 12/12/2012 | CN102813651A Pharmaceutical composition containing esomeprazole sodium, and preparation method thereof |
| 12/12/2012 | CN102813639A Mebendazole soft capsule |
| 12/12/2012 | CN102813638A Preparation method of dexketoprofen trometamol double-layer sustained-release tablets |
| 12/12/2012 | CN102813637A Kallidinogenase enteric coated tablet and preparation method thereof |
| 12/12/2012 | CN102813636A Nateglinide tablet and its preparation method |
| 12/12/2012 | CN102813635A Pharmaceutical composition |
| 12/12/2012 | CN102813634A Hydrotalcite tablet and its preparation method |
| 12/12/2012 | CN102813633A Method for preparing pharmaceutical composition containing macrolides antibiotics by using wet granulation |
| 12/12/2012 | CN102813632A Stable thymalfasin preparation and preparation method thereof |
| 12/12/2012 | CN102813629A Preparation method of tartaric acid valnemulin premixing agent |
| 12/12/2012 | CN102813628A Method for improving dissolubility of phlegm-contained traditional Chinese medicine formula granule |
| 12/12/2012 | CN102813626A Amorphous form cefmenoxime hydrochloride compound combination for injection |
| 12/12/2012 | CN102813625A Preparation method of tartaric acid valnemulin premixing agent |
| 12/12/2012 | CN102813624A Lidocaine ethosome and preparation method thereof |
| 12/12/2012 | CN102813622A Ornidazole sodium chloride injection composition and preparation method thereof |
| 12/12/2012 | CN102813621A Liquid pharmaceutical formulations of palonosetron |
| 12/12/2012 | CN102423294B Thermo sensitive in situ gel loaded with drug by chemical bonds, and preparation method thereof |
| 12/12/2012 | CN102406946B High molecular adriamycin bonded medicament and preparation method thereof |
| 12/12/2012 | CN102335172B Amlodipine and losartan potassium medicinal composition and preparation method thereof |
| 12/12/2012 | CN102319202B Mometasone furoate gel and preparation method thereof |
| 12/12/2012 | CN102274194B Pharmaceutical composition containing tropisetron compound and preparation method thereof |
| 12/12/2012 | CN102198096B ACA (acetoxychavicol acetate) submicron emulsion for intravenous injection, and preparation method and application thereof |
| 12/12/2012 | CN102188399B Torasemide gastric-floating tablet and preparation method thereof |
| 12/12/2012 | CN102144982B Minodronate tablets and preparation method thereof |
| 12/12/2012 | CN102144975B Cefprozil suspension pharmaceutical composition |
| 12/12/2012 | CN102138911B Divalproex sodium sustained release tablets and preparation method thereof |
| 12/12/2012 | CN102138894B Stable large-capacity fasudil hydrochloride injection |
| 12/12/2012 | CN102133204B Preparation method of melbinum osmotic pump controlled release tablets |
| 12/12/2012 | CN102127231B Glucan/polycaprolactone amphiphilic block polymer and preparation method and application thereof |
| 12/12/2012 | CN102114005B Tracleer capsule and preparation method thereof |
| 12/12/2012 | CN102091332B Self-assembly system based on hydrophilic polymer and medicine and preparation method thereof |
| 12/12/2012 | CN102068418B Sofalcone sustained-release pellet capsule preparation and preparation method thereof |
| 12/12/2012 | CN102058528B Daidzein micelles and preparation method thereof |
| 12/12/2012 | CN101987083B Preparation method for controlled release preparation, especial for zero-order release controlled release preparation |
| 12/12/2012 | CN101757641B Preparation technique of cardamom volatile oil inclusion complex |
| 12/12/2012 | CN101744863B Persimmon leaf extract preparation, preparing method thereof and application thereof |
| 12/12/2012 | CN101584889B External in-situ forming matrix used for treating periodontal diseases |
| 12/12/2012 | CN101547684B Ejection liquid and ejection method |
| 12/12/2012 | CN101524363B Artificial saliva |
| 12/12/2012 | CN101500584B Use of micron sulfur in prevention and treatment for pathogenic disorder of human or animal |
| 12/12/2012 | CN101484469B Method for the production of insulin-like growth factor-I |
| 12/11/2012 | US8329876 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
| 12/11/2012 | US8329760 Pharmaceutical composition |
| 12/11/2012 | US8329759 Long term weight maintenance |
| 12/11/2012 | US8329758 Preparing hand antiseptics having a high alcohol concentration (>60%) by neutralizing an aqueous dispersion of a carbopol" polymer by an hydroxide of sodium, potassium, ammonium or magnesium to effect gelation and obtain a gel of 4.1-4.8 pH; adding ethanol; microbiocides; bactericides; nontoxic (GRAS) |
| 12/11/2012 | US8329680 Formulation |
| 12/11/2012 | US8329679 Preformulation for tabletting natural mixtures of conjugated estrogens |
| 12/11/2012 | US8329654 Use of IL-6/IL-6 chimera in Huntington's disease |
| 12/11/2012 | US8329641 Antiischemic agents; anticholesterol agents; cardiovascular disorders; using granulocyte colony stimulating agents |
| 12/11/2012 | US8329431 Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17 |
| 12/11/2012 | US8329234 Mask pack comprising cosmetic cotton-like material prepared from paper mulberry |
| 12/11/2012 | US8329221 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients |
| 12/11/2012 | US8329215 Shell and core dosage form approaching zero-order drug release |
| 12/11/2012 | US8329214 Process for producing fenofibrate tablets |
| 12/11/2012 | US8329211 Reinforced absorbable multi-layered fabric for hemostatic applications |
| 12/11/2012 | US8329209 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 12/11/2012 | US8329208 Pharmacokinetics of S-adenosylmethionine formulations |
| 12/11/2012 | US8329207 Compositions and methods for the sustained release of beta-alanine |
| 12/11/2012 | US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 12/11/2012 | US8329070 Liposomal apparatus and manufacturing method |
| 12/11/2012 | CA2650202C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 12/11/2012 | CA2552679C Tulobuterol adhesive patch |
| 12/11/2012 | CA2552569C Direct compression formulation and process |
| 12/11/2012 | CA2548864C Percutaneous absorption-type pharmaceutical preparation |
| 12/11/2012 | CA2546172C Use of perfluoropolyethers phosphates as stabilizing agents for polyphenols in cosmetic and/or dermatological compositions |
| 12/11/2012 | CA2541396C Use of photosensitisation |
| 12/11/2012 | CA2540848C Method for stabilizing antibody and stabilized solution-type antibody preparation |
| 12/11/2012 | CA2507524C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 12/11/2012 | CA2495306C Water soluble metal and semiconductor nanoparticle complexes |
| 12/11/2012 | CA2484632C Processes for forming a drug delivery device |
| 12/11/2012 | CA2477516C Pharmaceutical formulation comprising melatonin |
| 12/11/2012 | CA2420061C Pharmaceutical composition for depot administration of rotigotine |
| 12/11/2012 | CA2328996C Implants for administering substances and methods of producing implants |
| 12/06/2012 | WO2012167271A1 Formulations of recombinant furin |
| 12/06/2012 | WO2012167223A1 Modified alginates for cell encapsulation and cell therapy |
| 12/06/2012 | WO2012167214A1 Compositions and methods for transport across the blood brain barrier |
| 12/06/2012 | WO2012167173A1 Anti-nucleolin agent-conjugated nanoparticles |
| 12/06/2012 | WO2012167088A1 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| 12/06/2012 | WO2012166923A2 Drug loaded polymeric nanoparticles and methods of making and using same |
| 12/06/2012 | WO2012166622A1 Therapeutic proteins with increased half-life and methods of preparing same |
| 12/06/2012 | WO2012166555A1 Water - soluble polymer - linked binding moiety and drug compounds |
| 12/06/2012 | WO2012166474A1 Controlled release solid dose forms |
| 12/06/2012 | WO2012165916A2 Non-peptidyl polymer-insulin multimer and method for producing the same |
| 12/06/2012 | WO2012165915A2 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate |
| 12/06/2012 | WO2012165815A2 Nano-vehicle derived from tumor tissue, and cancer vaccine using same |
| 12/06/2012 | WO2012165621A1 TABLET CONTAINING LIMAPROST AND β-CYCLODEXTRIN |
| 12/06/2012 | WO2012165468A1 Method for manufacturing liquid crystalline composition containing lipophilic compound in high concentration, and liquid crystalline composition manufactured by said method |
| 12/06/2012 | WO2012165356A1 Thermosensitive polyamino acid or salt thereof |
| 12/06/2012 | WO2012165309A1 Composition for external use |